Androgenic compounds induce an interaction between the NH 2 -and COOH-terminal regions (N-C interaction) of androgen receptor (AR). We describe a rapid yeast bioassay for androgenic and anti-androgenic compounds based on androgen-dependent -catenin-enhanced N-C interaction. The bioassay was also effective at detecting compounds that inhibit the N-C interaction in ways that do not involve binding to the ligand-binding domain.
Androgens such as testosterone and its metabolite dihydrotestosterone (DHT) act through binding to the androgen receptor (AR) not only in physiological processes such as male sexual differentiation and the development of bone, muscle, and reproductive tissues, but also in pathophysiological processes such as prostate tumor growth. 1) Androgen-bound AR interacts with androgen response elements (AREs) in the promoters of target genes and functions as a transcriptional factor. The recruitment of coactivators to AR enhances AR transactivation. The AR possesses three functional domains: an NH 2 -terminal domain (NTD), a central DNA-binding domain, and a COOH-terminal ligandbinding domain (LBD). 2) The binding of ligands to the LBD triggers intramolecular or intermolecular interaction between the NH 2 -and COOH-terminal regions (N-C interaction) of the AR. The N-C interaction is enhanced by certain coactivators including -catenin, 3) ARA24/Ran, 4) and p160 family proteins such as steroid receptor coactivator-1 (SRC-1) 5) and transcriptional intermediate factor-2 (TIF-2), 3) and is required for proper and maximal AR transactivation.
AR agonists and antagonists are expected to be effective for the prevention of male osteoporosis and for the inhibition of prostate cancer growth respectively. 6, 7) Accordingly, several bioassays for the detection of androgenic and anti-androgenic compounds have been developed using both mammalian and yeast cells. Mammalian-based assays have higher sensitivity for detection of androgenic activity than yeast-based assays, but yeast-based assays are simpler, more rapid, and cheaper than mammalian-based assays. Furthermore, there is no contamination of steroids in yeast-based assays, whereas in mammalian-based assays, steroidal compounds must be removed from the media because fetal bovine serum including various steroids is added to them.
Previous yeast bioassays based on interaction between a coactivator and the LBD of AR require grinding of cells and the addition of substrate for the reporter gene product (usually -galactosidase), which is timeconsuming and costly. To avoid these problems, a new yeast bioassay using a green fluorescent protein (GFP) as a reporter gene has been developed. However, the 50% effective concentration (EC 50 ) values of various steroids, including testosterone and DHT, are higher in bioassays using GFP than in bioassays usinggalactosidase. Here, we describe a new yeast bioassay based on the androgen-dependent N-C interaction, which is enhanced by -catenin and monitored by the fluorescence intensity of GFP. Furthermore, we report that resveratrol, which is a constituent of edible plant products such as peanuts and grape skin, inhibits the N-C interaction in our yeast-based bioassay, but not the androgen-dependent interaction between TIF-2 and the LBD of AR.
The bioassay to measure the N-C interaction was generated based on a yeast two-hybrid system. The cDNAs encoding the NTD and LBD of AR 4) were subcloned into pGADT7 and pGBKT7 (Clontech, Mountain View, CA) respectively. The resulting pGADT7-AR(NTD) and pGBKT7-AR(LBD) were expression vectors encoding GAL4AD-fused NTD (amino acids 1-557) and GAL4DBD-fused LBD (amino acids 622-917) respectively. To construct a reporter vector, the DNA encoding the GAL4-responsive GAL2 promoter region (À745 to þ17) was amplified by PCR and replaced with the CYC1 promoter region of p423CYC1 (American Type Culture Collection, Rockville, MD), termed p423GAL2. The cDNA that encodes yeast enhanced GFP (yEGFP) in pyEGFP3 (kindly provided by Dr. B. Cormack, Johns Hopkins University, MD) 8) was subcloned into p423GAL2 as a reporter gene, yielding p423GAL2-yEGFP3. Next, SRC-1 cDNA, y To whom correspondence should be addressed. Fax: +81-72-254-9921; E-mail: yamaji@biochem.osakafu-u.ac.jp Abbreviations: AR, androgen receptor; DHT, dihydrotestosterone; LBD, ligand-binding domain; NTD, NH 2 -terminal domain; SRC-1, steroid receptor coactivator-1; TIF-2, transcriptional intermediate factor-2; yEGFP, yeast enhanced green fluorescence protein TIF-2 cDNA, and -catenin cDNA were amplified by PCR and subcloned into p426GPD (American Type Culture Collection), and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA 9) and ARA24/Ran cDNA 4) were subcloned into p426GPD. To construct pGADT7-TIF-2, the cDNA encoding the region corresponding to amino acids 624-1,287 of TIF-2 was subcloned into pGADT7. When pGADT7-AR(NTD) and pGBKT7-AR(LBD) were transformed into Saccharomyces cerevisiae strain YPH499 (kindly provided by Yeast Genetic Resource Center, Osaka University, Osaka, Japan) with p423GAL2-yEGFP3, the fluorescent intensity increased in response to 10 nM DHT ( Fig. 1A) , indicating that the androgen-dependent N-C interaction of AR occurs in yeast. In addition, unlike other reporters such as -galactosidase, yEGFP protein can be used to measure activity in intact living cells directly.
Co-expression of AR coactivators, including -catenin, SRC-1, TIF-2, and ARA24/Ran, but not GAPDH, enhanced the N-C interaction of AR in the yeast (Fig. 1B) , in agreement with previous results for mammalian cells. [3] [4] [5] 10) Our results indicate that in yeast, the androgen-dependent N-C interaction is enhanced by certain coactivators. -Catenin is highly expressed in prostate cancer cells. 11) Hence a yeast bioassay based on the -catenin-enhanced N-C interaction was used throughout the subsequent experiments (termed the N-C/-catenin system).
TIF-2 interacts with LBDs of steroid hormone receptors, including AR, in a ligand-dependent manner.
To assess the effect of -catenin on the androgendependent interaction between TIF-2 and the LBD of AR, YPH499 yeast cells were transformed with pGBKT7-AR(LBD), pGADT7-TIF-2, and p423GAL2-yEGFP3 (the LBD-TIF-2 system). Co-expression of -catenin in the LBD-TIF-2 system had no influence on the interaction between LBD and TIF-2 (Fig. 1C) , indicating that -catenin has a specific role in the N-C interaction. Figure 1D shows the dose-response curves for DHT in the N-C/-catenin and LBD-TIF-2 systems. The N-C/-catenin system exhibited higher responsiveness to DHT than the LBD-TIF-2 system. The limit of detection of DHT in the N-C/-catenin system (2.5 nM) was comparable to that in a previous yeast-based yEGFP reporter bioassay (3 nM). 7) The dose-responses for various steroids were determined in the N-C/-catenin system. As shown in Fig. 2 , testosterone was active as well as DHT. 17-Estradiol and progesterone, but not dexamethasone, had androgenic effects at higher concentrations. The EC 50 values of DHT and testosterone in the present bioassay were estimated to be 6 nM and 18 nM respectively, comparable A, YPH499 cells were transformed with pGBKT7-AR(LBD) and/or pGADT7-AR(NTD), and p423GAL2-yEGFP3, followed by culture in the presence of 10 nM DHT or vehicle (DMSO) for 6 h. B, YPH499 cells with pGBKT7-AR(LBD) and pGADT7-AR(NTD) were further transformed with -catenin, SRC-1, TIF-2, ARA24/Ran, or GAPDH expression vector, and cultured in the presence and the absence of 10 nM DHT for 6 h. C, YPH499 cells with either the N-C interaction system or LBD-TIF-2 system were further transformed with -catenin expression vector and cultured in the presence and the absence of 10 nM DHT for 6 h. D, YPH499 cells with either the N-C/-catenin system or the LBD-TIF-2 system were cultured in the presence of DHT for 6 h. A-D, Fluorescence was measured at an excitation of 485 nm and an emission of 530 nm, and the OD at 595 nm was determined as the density of the yeast culture. Data are expressed as fluorescence/OD595 (fluorescence divided by OD at 595 nm), and values are indicated as means AE SD. All experiments were performed in triplicate. Each graph is representative of three independent experiments. Statistically significant differences (p < 0:05) were assessed by two-way ANOVA with Tukey's post hoc testing, and are indicated by different letters.
to the results for the yeast-based -galactosidase reporter bioassay (EC 50 values of DHT and testosterone: 4.8 nM and 15 nM respectively). 12) On the other hand, in the previous yeast-based yEGFP reporter bioassay, 7) the EC 50 values of DHT and testosterone are estimated at 33 nM and 76 nM respectively.
Next, to determine the anti-androgenic activities of AR antagonists, YPH499 yeast cells with the N-C/catenin system were incubated in the presence of 5 nM DHT and various concentrations of antagonist. The 50% inhibitory concentration (IC 50 ) values for flutamide, hydroxyflutamide, and cyproterone acetate were estimated at 3.8 mM, 8.8 mM, and 9.8 mM respectively in our bioassay. These values are comparable to the IC 50 values determined in the previous yeast-based -galactosidase reporter bioassay (IC 50 values for flutamide and cyproterone acetate, 4.5 mM and 5.1 mM respectively). 12) These results indicate that the present new yeast androgen bioassay is comparable to previous yeast-based bioassays with respect to sensitivity and specificity of detection for androgenic and anti-androgenic compounds.
Phytoestrogens such as genistein and resveratrol inhibit the androgen signal in prostate cancer. Hence we examined the effects of genistein and resveratrol on the N-C/-catenin and LBD-TIF-2 systems. Resveratrol, but not genistein, inhibited the -catenin-enhanced N-C interaction (Fig. 3A) . In contrast, neither resveratrol nor genistein influenced the DHT-induced interaction between the LBD and TIF-2. Flutamide, which binds to the LBD, inhibited not only the -catenin-enhanced N-C interaction, but also the interaction between LBD and TIF-2 in the presence of DHT. Next, yeast cells were cultured in the presence of various concentrations of resveratrol. Resveratrol inhibited the -cateninenhanced N-C interaction in a dose-dependent manner, and its IC 50 value was estimated at 8.4 mM (Fig. 3B) . We have found that resveratrol inhibits AR transactivation without binding to the LBD of AR. 13) We also found that resveratrol inhibited the N-C interaction of AR in human prostate cancer PC-3 cells (N. Harada, unpublished data). Taken together, our data indicate that the N-C/-catenin system can detect not only androgenic and anti-androgenic compounds that bind to the LBD of AR, but also compounds that inhibit the N-C interaction in ways that do not involve binding to the LBD. A, YPH499 cells with either the N-C/-catenin system or the LBD-TIF-2 system were exposed to 5 mM resveratrol, genistein, or flutamide in the presence of 5 nM DHT for 6 h. B, YPH499 cells with either the N-C/-catenin system or the LBD-TIF-2 system were exposed to various concentrations of resveratrol in the presence of 5 nM DHT for 6 h. Data are expressed as fluorescence/OD595. All experiments were performed in triplicate, and all values are indicated as means AE SD. Each graph is representative of three independent experiments. Statistically significant differences (p < 0:05) were assessed by two-way ANOVA with Tukey's post hoc testing and indicated by different letters.
